ESC 365 - Quo vadis, the leading arrhythmia? Projecting the prevalence of atrial fibrillation up to 2070

ESC Professional Premium Access

Quo vadis, the leading arrhythmia? Projecting the prevalence of atrial fibrillation up to 2070

Session: Risk factors for atrial fibrillation and stroke prediction

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor M. Lehto (Helsinki, FI)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Mika Lehto

Helsinki University Hospital, Helsinki (Finland)

0 follower

7 more presentations in this session

Temporal and age-related trends in risk factors for development of atrial fibrillation in peripartum patients

Speaker: Doctor B. Ali (Cleveland, US)

Predictors of new-onset in-hospital atrial fibrillation in 122 089 patients admitted with COVID-19: an Australian statewide population study

Speaker: Doctor J. Ne (Concord, AU)

Socioeconomic deprivation and atrial fibrillation risk: an observational and gene-environment interaction analysis

Speaker: Doctor K. Lee (Seoul, KR)

Left atrial enlargement: a crucial indicator for identifying atrial fibrillation in patients with hypertension

Speaker: Doctor X. Yi (Chongqing, CN)

Long-term changes in frailty and incident atrial fibrillation: multicenter prospective cohort study

Speaker: Doctor L. Cai (Shanghai, CN)

Access the full session

Risk factors for atrial fibrillation and stroke prediction

Speakers: Doctor M. Lehto, Doctor B. Ali, Doctor J. Ne, Doctor K. Lee, Doctor X. Yi...

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources